JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 43:55-60, doi:10.1016/j.jacc.2003.07.037
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Masuyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Masuyama, T.

CLINICAL RESEARCH: HEART FAILURE

Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy

Hitoshi Yamaguchi, MD, PhD*,{ddagger}, Junichi Yoshida, MD{dagger},{ddagger}, Kazuhiro Yamamoto, MD, PhD, FACC{dagger},*, Yasushi Sakata, MD, PhD{dagger}, Toshiaki Mano, MD, PhD{dagger}, Noriyuki Akehi, MD{dagger}, Masatsugu Hori, MD, PhD, FACC{dagger}, Young-Jae Lim, MD, PhD*, Masayoshi Mishima, MD, PhD* and Tohru Masuyama, MD, PhD, FACC{dagger}

* Department of Cardiology, Kawachi General Hospital, Higashi-Osaka, Japan
{dagger} Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Suita, Japan

Manuscript received April 4, 2003; revised manuscript received June 12, 2003, accepted July 29, 2003.

* Reprint requests and correspondence: Dr. Kazuhiro Yamamoto, Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita 565-0871, Japan.
kazuhiro{at}medone.med.osaka-u.ac.jp

OBJECTIVES: We tested a hypothesis that elevation of the plasma level of brain natriuretic peptide (BNP) is one of the characteristics of patients with diastolic heart failure (DHF) independent of left ventricular (LV) hypertrophy.

BACKGROUND: The clinical characteristics of DHF are not well acknowledged, although DHF has become a great social burden. Such a lack of clinical information leads to inaccuracy in the diagnosis of DHF. We have demonstrated enhancement of ventricular production of BNP with progression of maladaptive ventricular hypertrophy, but not with development of compensatory hypertrophy in an animal DHF model.

METHODS: Of 372 patients who presented to the emergency department because of acute pulmonary congestion without acute coronary syndrome between January 1996 and May 2002, those with an ejection fraction ≥45% upon admission, who were stably controlled at least for a year in our outpatient clinics, comprised the DHF group (n = 19). A control group consisted of 22 hypertensive patients with a LV mass index greater than or equal to its minimum value of the DHF group and an ejection fraction ≥45%, in whom cardiac symptoms had not occurred.

RESULTS: Despite a similar distribution of LV mass index, the BNP level was higher in the DHF group than in the control group (149 ± 38 vs. 31 ± 5 pg/ml, p < 0.01). There was no difference in LV cavity size or parameters derived from pulsed Doppler transmitral flow velocity curves.

CONCLUSIONS: An elevation of BNP may be a hallmark of patients with or at risk of DHF among subjects with preserved systolic function independent of LV hypertrophy.

Abbreviations and Acronyms
  ANP = atrial natriuretic peptide
  BNP = brain natriuretic peptide
  DHF = diastolic heart failure
  E/A = ratio of peak mitral E-wave velocity to peak mitral A-wave velocity
  EF = ejection fraction
  HF = heart failure
  LV = left ventricular
  NYHA = New York Heart Association




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. B. Daniels and A. S. Maisel
Natriuretic Peptides
J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2357 - 2368.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Herrmann, O. Taban-Shoma, U. Hubner, A. Pexa, H. Kilter, N. Umanskaya, R. Hans Straub, M. Bohm, and W. Herrmann
Hyperhomocysteinemia and Myocardial Expression of Brain Natriuretic Peptide in Rats
Clin. Chem., April 1, 2007; 53(4): 773 - 780.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Ohtani, M. Ohta, K. Yamamoto, T. Mano, Y. Sakata, M. Nishio, Y. Takeda, J. Yoshida, T. Miwa, M. Okamoto, et al.
Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R946 - R954.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Herrmann, S. Muller, I. Kindermann, L. Gunther, J. Konig, M. Bohm, and W. Herrmann
Plasma B vitamins and their relation to the severity of chronic heart failure
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 117 - 123.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
I. Ben-Dor, M. Haim, E. Rechavia, D. Murninkas, D. Harell, A. Porter, Z. Iakobishvili, A. Battler, and D. Hasdai
Serum NT-proBNP Concentrations in the Early Phase Do Not Predict the Severity of Systolic or Diastolic Left Ventricular Dysfunction Among Patients With ST-Elevation Acute Myocardial Infarction
Angiology, January 1, 2007; 57(6): 686 - 693.
[Abstract] [PDF]


Home page
Eur Heart JHome page
R. J. Shelton, A. L. Clark, K. Goode, A. S. Rigby, and J. G.F. Cleland
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation
Eur. Heart J., October 1, 2006; 27(19): 2353 - 2361.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. M. McKie, R. J. Rodeheffer, A. Cataliotti, F. L. Martin, L. H. Urban, D. W. Mahoney, S. J. Jacobsen, M. M. Redfield, and J. C. Burnett Jr
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure
Hypertension, May 1, 2006; 47(5): 874 - 880.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Watanabe, J. Shite, H. Takaoka, T. Shinke, Y. Imuro, T. Ozawa, H. Otake, D. Matsumoto, D. Ogasawara, O. L. Paredes, et al.
Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure
Eur. Heart J., April 1, 2006; 27(7): 832 - 838.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Tschope, M. Kasner, D. Westermann, R. Gaub, W. C. Poller, and H.-P. Schultheiss
The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements
Eur. Heart J., November 1, 2005; 26(21): 2277 - 2284.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Yoshida, K. Yamamoto, T. Mano, Y. Sakata, M. Nishio, T. Ohtani, M. Hori, T. Miwa, and T. Masuyama
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats
Cardiovasc Res, October 1, 2005; 68(1): 118 - 127.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Fiorina, C. Gremizzi, P. Maffi, R. Caldara, D. Tavano, L. Monti, C. Socci, F. Folli, F. Fazio, E. Astorri, et al.
Islet Transplantation Is Associated With an Improvement of Cardiovascular Function in Type 1 Diabetic Kidney Transplant Patients
Diabetes Care, June 1, 2005; 28(6): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Souza, H. B. Bogossian, M. Humbert, C. Jardim, R. Rabelo, M. B. P. Amato, and C. R. R. Carvalho
N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Eur. Respir. J., March 1, 2005; 25(3): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Sharp and J. Mayet
Review: The utility of BNP in clinical practice
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2004; 5(2): 53 - 58.
[Abstract] [PDF]


Home page
NEJMHome page
D. B. Mark and G. M. Felker
B-Type Natriuretic Peptide -- A Biomarker for All Seasons?
N. Engl. J. Med., February 12, 2004; 350(7): 718 - 720.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.